Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
Jazz Pharmaceuticals
Jazz Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Genome & Company
Yonsei University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Eli Lilly and Company
Merck Sharp & Dohme LLC
Peking Union Medical College Hospital
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
TiumBio Co., Ltd.
Sotio Biotech Inc.
Carisma Therapeutics Inc
Eli Lilly and Company
European Organisation for Research and Treatment of Cancer - EORTC
Samsung Medical Center
SMT bio Co., Ltd.
University of California, San Francisco
National Institutes of Health Clinical Center (CC)